Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Andrews

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Lower Genital Tract Disease|August 7, 2015
Lower Anogenital Tract Disease Therapy Outcomes, COMET, and CROWN: Call for Research SubmissionsJeffrey Andrews
Science (New York, N.Y.)|March 16, 2013
Ecology. Not all about consumptionDebra J Davidson, Jeffrey Andrews
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2024
Bridging theory and data: A computational workflow for cultural evolutionDominik Deffner, Natalia Fedorova, Jeffrey Andrews, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|September 30, 2022
Practical guide to coproduction in conservation scienceTim Caro, Jeffrey Andrews, Matthew Clark, et al.
Gynecologic Oncology|May 7, 2023
Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trialMark H Stoler, Valentin Parvu, Karen Yanson, et al.
Anesthesiology|December 27, 2003
Bulk liquid oxygen supply failureShawn D Schumacher, Russell C Brockwell, J Jeffrey Andrews, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|April 4, 2024
Effects of perceptions of forest change and intergroup competition on community-based conservation behaviorsMatt Clark, Haji Masoud Hamad, Jeffrey Andrews, et al.
Gynecologic Oncology|June 5, 2019
Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytologyThomas C Wright, Mark H Stoler, Valentin Parvu, et al.
Gynecologic Oncology|March 5, 2026
HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assayDidier Morel, Valentin Parvu, Jeffrey Andrews, et al.
Gynecologic Oncology|January 15, 2019
Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytologyMark H Stoler, Thomas C Wright, Valentin Parvu, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Lower Genital Tract Disease|August 7, 2015
Lower Anogenital Tract Disease Therapy Outcomes, COMET, and CROWN: Call for Research SubmissionsJeffrey Andrews
Science (New York, N.Y.)|March 16, 2013
Ecology. Not all about consumptionDebra J Davidson, Jeffrey Andrews
Proceedings of the National Academy of Sciences of the United States of America|November 18, 2024
Bridging theory and data: A computational workflow for cultural evolutionDominik Deffner, Natalia Fedorova, Jeffrey Andrews, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|September 30, 2022
Practical guide to coproduction in conservation scienceTim Caro, Jeffrey Andrews, Matthew Clark, et al.
Gynecologic Oncology|May 7, 2023
Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trialMark H Stoler, Valentin Parvu, Karen Yanson, et al.
Anesthesiology|December 27, 2003
Bulk liquid oxygen supply failureShawn D Schumacher, Russell C Brockwell, J Jeffrey Andrews, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|April 4, 2024
Effects of perceptions of forest change and intergroup competition on community-based conservation behaviorsMatt Clark, Haji Masoud Hamad, Jeffrey Andrews, et al.
Gynecologic Oncology|June 5, 2019
Risk detection for high-grade cervical disease using Onclarity HPV extended genotyping in women, ≥21 years of age, with ASC-US or LSIL cytologyThomas C Wright, Mark H Stoler, Valentin Parvu, et al.
Gynecologic Oncology|March 5, 2026
HPV genotype prevalence in low- and high-vaccine coverage, USA populations: Data from real-world cervical cancer screening using the Onclarity HPV assayDidier Morel, Valentin Parvu, Jeffrey Andrews, et al.
Gynecologic Oncology|January 15, 2019
Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytologyMark H Stoler, Thomas C Wright, Valentin Parvu, et al.
Pageof 2